BREAST CANCER RECURRENT
Clinical trials for BREAST CANCER RECURRENT explained in plain language.
Never miss a new study
Get alerted when new BREAST CANCER RECURRENT trials appear
Sign up with your email to follow new studies for BREAST CANCER RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill targets cancer cell machinery in First-Ever human trial
Disease control Recruiting nowThis is the first study in people to test a new oral drug called ATX-295, which works by blocking a specific protein that helps cancer cells divide. The main goals are to find a safe dose and see how the body processes the drug in about 90 patients with advanced solid tumors, inc…
Matched conditions: BREAST CANCER RECURRENT
Phase: PHASE1 • Sponsor: Accent Therapeutics • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
Heating up the fight: UK trial tests adding heat to cancer treatment
Disease control Recruiting nowThis study is testing whether adding a special heat treatment to standard palliative radiotherapy helps control advanced cancers that cannot be cured by surgery. It will involve about 60 patients with certain advanced head, neck, skin, or breast cancers. The goal is to see if the…
Matched conditions: BREAST CANCER RECURRENT
Phase: NA • Sponsor: King's College London • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Scientists grow patient tumors in mice to predict Cancer's return
Disease control Recruiting nowThis study aims to predict and prevent aggressive breast cancer from returning after initial treatment. Researchers will grow patients' tumor samples in mice and test drugs on them to create personalized treatment plans. If the cancer returns, doctors will use these test results …
Matched conditions: BREAST CANCER RECURRENT
Phase: PHASE2 • Sponsor: University of Utah • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
One-Week radiation offers new hope to women facing breast cancer again
Disease control Recruiting nowThis study is testing a new, shorter radiation schedule for women whose breast cancer has returned in a previously treated breast. Instead of the standard 3-5 weeks of treatment, participants receive radiation focused only on the tumor area over just 5 days (one week). The main g…
Matched conditions: BREAST CANCER RECURRENT
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC